Related Experiment Videos
Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains
1Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, UK.
Abstract:
The MDM2 oncoprotein is a negative regulatory partner of the p53 tumour suppressor. MDM2 mediates ubiquitination of p53 and targets the protein to the cytoplasm for 26S proteosome-dependent degradation. In this paper, we show that MDM2 is modified in cultured cells by multisite phosphorylation. Deletion analysis of MDM2 indicated that the sites of modification fall into two clusters which map respectively within the N-terminal region encompassing the p53 binding domain and nuclear export sequence, and the central acidic domain that mediates p14(ARF) binding, p53 ubiquitination and cytoplasmic shuttling. The data are consistent with potential regulation of MDM2 function by multisite phosphorylation.
Insights
Multisite phosphorylation modifies the MDM2 oncoprotein, a key regulator of the p53 tumor suppressor. These modifications, occurring in specific regions of MDM2, suggest a regulatory role in its cellular functions.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- The MDM2 oncoprotein negatively regulates the p53 tumor suppressor.
- MDM2 mediates p53 ubiquitination and subsequent proteasomal degradation.
- MDM2 plays a critical role in controlling p53 levels and activity.
Purpose of the Study:
- To investigate post-translational modifications of the MDM2 oncoprotein.
- To identify the specific sites and functional domains of MDM2 modification.
- To explore the potential regulatory impact of these modifications on MDM2 function.
Main Methods:
- Cell culture techniques to study MDM2 modification.
- Deletion analysis of the MDM2 protein.
- Phosphorylation site mapping within MDM2.
Main Results:
- MDM2 undergoes multisite phosphorylation in cultured cells.
- Two main clusters of phosphorylation sites were identified in MDM2.
- These sites are located in the N-terminal (p53 binding, NES) and central acidic domains.
Conclusions:
- Multisite phosphorylation potentially regulates MDM2's interaction with p53.
- Modification sites are associated with key MDM2 functions like p53 binding and nuclear export.
- Phosphorylation may control MDM2's role in p53 ubiquitination and degradation.